Related Experiment Videos
Sickle cell anemia: pathophysiology, management, and prospects for the future
1Department of Medicine, University of Mississippi School of Medicine, Jackson.
Journal of Clinical Apheresis
|January 1, 1991
Summary
Sickle cell anemia affects many Black Americans, causing severe health issues and premature death. Research is leading to innovative therapies and improved patient care for this genetic blood disorder.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Sickle cell anemia (SCA) is a prevalent inherited blood disorder affecting approximately 1 in 600 Black Americans.
- The disease causes significant morbidity, including chronic pain, organ damage, and reduced lifespan.
- Current understanding of SCA encompasses its molecular, cellular, and clinical manifestations.
Purpose of the Study:
- To review the pathophysiology of sickle cell anemia.
- To highlight current therapeutic strategies for managing the disorder.
- To discuss emerging therapies aimed at preventing sickle cell anemia complications.
Main Methods:
- Literature review of existing research on sickle cell anemia.
- Analysis of molecular and cellular mechanisms underlying the disease.
- Evaluation of current and novel treatment approaches.
Main Results:
- Detailed understanding of SCA's pathophysiology is established.
- Existing treatments focus on symptom management and complication prevention.
- New therapies offer potential for more direct disease modification.
Conclusions:
- Significant advancements in understanding sickle cell anemia have been made.
- Therapeutic landscape is evolving with innovative treatments.
- Future therapies hold promise for improved long-term outcomes and reduced disease burden.